Lupin consolidated net surges by 39% in Q2 to Rs 160 crore

Lupin, a Mumbai based major pharmaceutical company, has recorded impressive performance during the second quarter ended September 2009 with significant growth in international business. It’s consolidated net profit jump by 38.6 per cent to Rs 160.30 crore from Rs 115.62 crore in the corresponding period of last year. The consolidated net sales moved up by 22.7 per cent to Rs 1,115 crore from Rs 908.37 crore. The earnings per share worked out to Rs 18.99 as against Rs 14.07 in the last period.

The company’s international sales increased by 31.7 per cent to Rs 747 crore from Rs 567 crore in the similar second quarter of last year. Sales in India grew by 14.1 per cent to Rs 418.65 crore from Rs 367.05 crore.

Comments

Post a Comment

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Image
GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut    Vox Author of GOP Tax Plan Says Children's Health Insurance Program Is Held Up “Because We Don't Have Money ...    The Intercept Nevada wins short reprieve in child health care funds fight    Sacramento Bee Ben McAdams: Congress to Tiny Tim: 'No health insurance for you.'    Salt Lake Tribune Full coverage
Read more

Trump wants more mental health care; Alabama says it's trying

Image
Trump wants more mental health care; Alabama says it's trying    AL.com Budget undercuts Trump focus on mental health, school safety    Yahoo News Mental health awareness license plates offered by New York State DMV    Buffalo News Trump wants to 'tackle the difficult issue of mental health?' He should put his money where his mouth is.    Washington Post Full coverage
Read more